All SARS-CoV-2 articles – Page 6
-
NewsKIST develops multifunctional peptide that fights viruses and promotes wound healing
Researchers announced that they have developed a therapeutic substance with both antiviral and tissue regenerative properties, based on a peptide derived from natural sources.
-
NewsSARS-CoV-2 corrupts some white blood cells to suppress immune system, suggesting path to severe COVID
A study found that neutrophils may be altered by SARS-CoV-2, the virus that causes COVID-19, to cease their normal function of destroying pathogens in the body and, instead, significantly inhibit other immune cells critical for fighting the virus.
-
CareersHow structural imaging is revolutionising vaccines
Dr. Peijun Zhang, Director of the Electron Bio-Imaging Centre (eBIC) at the UK’s national synchrotron facility Diamond Light Source, reveals how Cryo-ET is powering some of the most important advances in vaccine research.
-
NewsPost-COVID syndrome: new insights into connection between gut health and fatigue
A new study shows that post-COVID syndrome patients have altered inflammatory markers and a disturbed intestinal barrier, which could contribute to the development of post-viral fatigue.
-
NewsEngineered bacteria can deliver antiviral therapies and vaccines
New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines.
-
NewsA gene variant increases the risk of long COVID
An international team of researchers has found a genetic link to long-term symptoms after COVID-19. The identified gene variant is located close to the FOXP4 gene, which is known to affect lung function.
-
NewsResearchers reveal remarkable antimicrobial activity in hydrogen boride nanosheets
Hydrogen boride (HB) nanosheets represent an exciting new frontier in the search for technologies that can combat microbes in everyday settings. Researchers discovered that they exhibit excellent antibacterial, antiviral, and antifungal properties.
-
NewsAI-powered framework predicts the evolutionary fitness of SARS-CoV-2 variants
CoVFit is a novel framework designed to predict the fitness of SARS-CoV-2 variants. It integrates molecular data with large-scale epidemiological data to provide a predictive model that helps us understand why some variants succeed while others do not.
-
NewsSegregation fuels faster spread of infectious diseases, study finds
Structural inequalities, including wealth inequality and social segregation, not only make certain groups more vulnerable during public health crises but also accelerate the spread of infectious diseases through society, according to a team of international researchers.
-
NewsWorld Health Assembly adopts historic Pandemic Agreement to make the world more equitable and safer from future pandemics
Member States of the World Health Organization (WHO) today formally adopted by consensus the world’s first Pandemic Agreement, following more than three years of intensive negotiations launched by governments in response to the COVID-19 pandemic.
-
NewsScientists find two brain biomarkers in long COVID sufferers may be what’s causing brain fog
A new study that compares inflammation and brain stress responses in long COVID-19 patients with individuals who have fully recovered shows those with cognitive issues have a lower ability to adapt to stress and higher levels of inflammation in their brains.
-
NewsWorld’s largest bat organoid platform paves the way for pandemic preparedness
Researchers have created the world’s most comprehensive bat organoid platform. These ’mini-organs’ are grown from five common bat species found across Asia and Europe and represent four different organs—airway, lungs, kidneys, and small intestine.
-
NewsNew study offers insights into designing safe, effective nasal vaccines
Researchers found that nasal vaccine boosters can trigger strong immune defenses in the respiratory tract, even without the help of immune-boosting ingredients known as adjuvants. The findings, researchers suggest, may offer critical insights into developing safer, more effective nasal vaccines in the future.
-
NewsNew discovery explains why men are more affected by severe COVID-19
Researchers have found another piece of the puzzle that explains why there are differences in immune responses in women and men when they get sick with COVID-19. This discovery has implications for treatment strategies for severe COVID-19.
-
NewsCOVID-19 caused by the Omicron variant in lung transplant recipients: a single center case series
A new study investigates the risk factors for developing severe disease in lung transplant patients as a result of the Omicron variant of Covid-19.
-
NewsForever chemicals influence cellular immune response to coronavirus
A new study shows that PFAS influence the cellular immune response to coronavirus and also reveals sex-specific differences as to how the immune system reacts to the virus.
-
NewsNew study shows obesity linked to long COVID
New research has found that people with excess weight are more likely to experience long-term neurological and mental health symptoms after COVID-19, including headache, vertigo, smell and taste disorders, sleep disturbance, and depression.
-
NewsPredictive AI model can help build vaccines for future versions of a virus
Researchers have created an AI tool called EVE-Vax that can predict and design viral proteins likely to emerge in the future. For SARS-CoV-2, panels of these “designer” proteins triggered similar immune responses as real-life viral proteins that emerged during the pandemic.
-
NewsFoot traffic can predict COVID-19 spread in New York City neighborhoods
A new study reveals how foot traffic data from mobile devices can enhance neighborhood-level COVID-19 forecasts in New York City, providing a novel approach to predicting the spread of the SARS-CoV-2 virus and improving targeted public health interventions.
-
OpinionIt’s game over for dangerous Gain of Function research
The Trump adminstration has signed an Executive Order halting federal gain of function research on microbes - but does it throw the baby out with the bathwater? Virologist Simon Wain-Hobson, Emeritus Professor with the Pasteur Institute, Paris, gives his take.